deltatrials
Unknown PHASE3 INTERVENTIONAL 2-arm NCT00407186

Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS)

A Multicenter Randomized Phase III Trial of Neo-adjuvant Chemotherapy Followed by Surgery and Chemotherapy or by Surgery and Chemoradiotherapy in Resectable Gastric Cancer (CRITICS Study)

Sponsor: Dutch Colorectal Cancer Group

Conditions Gastric Cancer
Interventions cisplatin+capecitabine epirubicin+cisplatin+capecitabine radiotherapy
Updated 7 times since 2017 Last updated: Oct 9, 2017 Started: Jan 11, 2007 Primary completion: Dec 31, 2018 Completion: Dec 31, 2025
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00407186, this PHASE3 trial focuses on Gastric Cancer and remains ongoing. Sponsored by Dutch Colorectal Cancer Group, it has been updated 7 times since 2007, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Oct 2017 · 9 months · monthly snapshotUnknown Status~Oct 2017 – ~Jun 2018 · 8 months · monthly snapshotActive Not Recruiting~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotActive Not Recruiting~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotActive Not Recruiting~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotActive Not Recruiting~Sep 2024 – ~Feb 2026 · 17 months · monthly snapshotActive Not Recruiting~Feb 2026 – present · 5 months · monthly snapshotUnknown

Change History

7 versions recorded

  1. Feb 2026 — Present [monthly]

    Unknown PHASE3

    Status: Active Not Recruiting → Unknown

  2. Sep 2024 — Feb 2026 [monthly]

    Active Not Recruiting PHASE3

  3. Jul 2024 — Sep 2024 [monthly]

    Active Not Recruiting PHASE3

  4. Jan 2021 — Jul 2024 [monthly]

    Active Not Recruiting PHASE3

  5. Jun 2018 — Jan 2021 [monthly]

    Active Not Recruiting PHASE3

▶ Show 2 earlier versions

  1. Oct 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE3

    Status: Unknown Status → Active Not Recruiting

  2. Jan 2017 — Oct 2017 [monthly]

    Unknown Status PHASE3

    First recorded

Jan 2007

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Dutch Colorectal Cancer Group
  • Roche Pharma AG
  • The Netherlands Cancer Institute
Data source: Dutch Colorectal Cancer Group

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations